A biosimilar is a type of biologic product that is licensed by the FDA because it is highly similar to a biological product that is already FDA-approved. This originally approved product is known as the biological reference product (or reference product), and the biosimilar has been shown to have no clinically meaningful differences in potency, safety, and purity compared with that of its reference product.
